Filed pursuant to Rule 424(b)(3)

SEC File No. 333-258223

PROSPECTUS SUPPLEMENT NO. 2

(to Prospectus dated October 5, 2021)

 

LOGO

ironSource Ltd.

102,869,375 CLASS A ORDINARY SHARES

 

 

This prospectus supplement updates, amends and supplements the prospectus contained in our Post-Effective Amendment No. 1 to our Registration Statement on Form F-1, effective as of October 4, 2021 (as supplemented or amended from time to time, the “Prospectus”) (Registration No. 333-258223). Capitalized terms used in this prospectus supplement and not otherwise defined herein have the meanings specified in the Prospectus.

This prospectus supplement is being filed to update, amend and supplement the information included in the Prospectus with information on ironSource’s third quarter 2021 financial results, which is set forth below.

This prospectus supplement is not complete without the Prospectus. This prospectus supplement should be read in conjunction with the Prospectus, which is to be delivered with this prospectus supplement, and is qualified by reference thereto, except to the extent that the information in this prospectus supplement updates or supersedes the information contained in the Prospectus. Please keep this prospectus supplement with your Prospectus for future reference.

Our Class A ordinary shares are listed on the New York Stock Exchange under the symbol “IS.” On November 9, 2021, the closing price for our Class A ordinary shares on the New York Stock Exchange was $12.04 per share.

 

 

Investing in our securities involves a high degree of risk. See “Risk Factors” beginning on page 28 of the Prospectus and other risk factors contained in the documents incorporated by reference therein for a discussion of information that should be considered in connection with an investment in our securities.

Neither the Securities and Exchange Commission, the Israeli Securities Authority nor any state securities commission has approved or disapproved of these securities or determined if the Prospectus or this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.

 

 

The date of this prospectus supplement is November 10, 2021.


IRONSOURCE LTD.

CONDENSED CONSOLIDATED BALANCE SHEETS

(U.S. dollars in thousands, except for number of shares and par value)

(Unaudited)

 

     September 30,      December 31,  
     2021      2020  

Assets

     

Current assets:

     

Cash and cash equivalents

   $ 787,961      $ 200,672  

Short-term deposits

     —          17,627  

Accounts receivable, net of allowances of $761 and $724 as of September 30, 2021 and December 31, 2020, respectively

     188,994        151,503  

Other current assets

     32,920        15,711  
  

 

 

    

 

 

 

Total current assets

     1,009,875        385,513  

Long-term restricted cash

     2,912        2,415  

Deferred tax assets

     3,344        161  

Operating lease right-of-use asset

     32,306        36,780  

Property, equipment and software, net

     24,791        23,077  

Investment in equity securities

     20,000        —    

Goodwill

     205,842        79,156  

Intangible assets, net

     29,677        8,084  

Other non-current assets

     6,774        650  
  

 

 

    

 

 

 

Total assets

   $ 1,335,521      $  535,836  
  

 

 

    

 

 

 


IRONSOURCE LTD.

CONDENSED CONSOLIDATED BALANCE SHEETS

(U.S. dollars in thousands, except for number of shares and par value)

(Unaudited)

 

     September 30     December 31,  
     2021     2020  

Liabilities and shareholders’ equity

    

Current liabilities:

    

Accounts payable

   $ 213,205     $  155,476  

Current maturities of long-term loan

     —         9,725  

Operating lease liabilities

     6,002       7,429  

Other current liabilities

     38,991       34,034  
  

 

 

   

 

 

 

Total current liabilities

     258,198       206,664  

Long-term loan, net of current maturities

     —         74,684  

Deferred tax liabilities

     1,163       2,521  

Long-term operating lease liabilities

     28,655       32,241  

Other non-current liabilities

     1,555       280  
  

 

 

   

 

 

 

Total liabilities

     289,571       316,390  
  

 

 

   

 

 

 

Commitments and contingencies

    

Shareholders’ equity:

    

Class A ordinary share, no par value; 10,000,000,000 shares authorized at September 30, 2021 and December 31, 2020; 631,082,097 and 320,133,022 issued and outstanding at September 30, 2021 and December 31, 2020, respectively (1)

     —         —    

Class B ordinary share, no par value; 1,500,000,000 shares authorized at September 30, 2021 and December 31, 2020; 384,150,417 and 320,133,022 issued and outstanding at September 30, 2021 and December 31, 2020, respectively (1)

     —         —    

2019 ordinary shares, NIS 0.01 par value, 25,006,298 authorized, issued and outstanding at December 31, 2020

     —         72  

Treasury shares, at cost, 6,745,955 Class A ordinary shares held at September 30, 2021

     (67,460     —    

Additional paid-in capital (1)

     1,007,271       152,251  

Retained earnings

     106,139       67,123  
  

 

 

   

 

 

 

Total shareholders’ equity

     1,045,950       219,446  
  

 

 

   

 

 

 

Total liabilities and shareholders’ equity

   $ 1,335,521     $  535,836  
  

 

 

   

 

 

 

 

(1) 

Per share amounts have been adjusted, on a retroactive basis, for all periods presented, to reflect both the distribution of Class B ordinary shares and the Stock Split, together representing a ratio of 9.98 of each share.


IRONSOURCE LTD.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(U.S. dollars in thousands, except share and per share amounts)

(Unaudited)

 

     Three Months Ended
September 30,
     Nine Months Ended
September 30,
 
     2021      2020      2021      2020  

Revenue

   $ 140,446      $ 88,001      $ 395,195      $ 223,165  

Cost of revenue

     21,756        15,416        64,661        40,519  
  

 

 

    

 

 

    

 

 

    

 

 

 

Gross profit

     118,690        72,585        330,534        182,646  
  

 

 

    

 

 

    

 

 

    

 

 

 

Operating expenses:

           

Research and development

     24,073        12,851        67,644        34,451  

Sales and marketing

     51,001        29,805        151,903        77,216  

General and administrative

     20,212        6,353        56,445        19,836  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total operating expenses

     95,286        49,009        275,992        131,503  
  

 

 

    

 

 

    

 

 

    

 

 

 

Income from operations

     23,404        23,576        54,542        51,143  

Financial expenses, net

     55        434        2,061        2,610  
  

 

 

    

 

 

    

 

 

    

 

 

 

Income from continuing operations before income taxes

     23,349        23,142        52,481        48,533  

Income taxes

     4,581        3,256        13,465        7,044  
  

 

 

    

 

 

    

 

 

    

 

 

 

Income from continuing operations, net of income taxes

     18,768        19,886        39,016        41,489  

Income from discontinued operations, net of income taxes

     —          6,991        —          31,779  
  

 

 

    

 

 

    

 

 

    

 

 

 

Net income

   $ 18,768      $ 26,877      $ 39,016      $ 73,268  
  

 

 

    

 

 

    

 

 

    

 

 

 

Basic net income per ordinary share: (1)

           

Continuing operations

     0.02        0.02        0.04        0.05  

Discontinued operations

     —          0.01        —          0.03  
  

 

 

    

 

 

    

 

 

    

 

 

 

Basic net income per ordinary share

   $ 0.02      $ 0.03      $ 0.04      $ 0.08  
  

 

 

    

 

 

    

 

 

    

 

 

 

Weighted-average ordinary shares outstanding – basic

     1,014,267,611        636,578,068        772,837,797        635,526,458  
  

 

 

    

 

 

    

 

 

    

 

 

 

Diluted net income per ordinary share: (1)

           

Continuing operations

     0.02        0.02        0.04        0.04  

Discontinued operations

     —          0.01        —          0.04  
  

 

 

    

 

 

    

 

 

    

 

 

 

Diluted net income per ordinary share

   $ 0.02      $ 0.03      $ 0.04      $ 0.08  
  

 

 

    

 

 

    

 

 

    

 

 

 

Weighted-average ordinary shares outstanding – diluted

     1,095,048,098        688,072,259        851,235,852        679,226,389  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

(1) 

Per share amounts have been adjusted, on a retroactive basis, for all periods presented, to reflect both the distribution of Class B ordinary shares and the Stock Split, together representing a ratio of 9.98 of each share.


IRONSOURCE LTD.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(U.S. dollars in thousands)

(Unaudited)

 

     Three months Ended
September 30,
    Nine months Ended
September 30,
 
     2021     2020     2021     2020  
     (Unaudited)     (Unaudited)  

Cash flows from operating Activities

        

Net income from continuing operations

   $ 18,768     $ 19,886     $ 39,016     $ 41,489  

Adjustments to reconcile net income to net cash provided by operating activities:

        

Depreciation and amortization

     6,211       4,091       17,428       12,230  

Share-based compensation expenses

     20,327       2,250       57,801       7,591  

Non-cash lease expense

     (1,381     330       (539     320  

Effect of exchange rate changes on cash and cash equivalents and restricted cash

     (676     (436     (815     12  

Gain on disposal of fixed assets

     (17     —         (17     —    

Interest accrued and other financial expenses

     —         53       628       161  

Deferred income taxes, net

     194       (603     (534     (1,298

Changes in operating assets and liabilities:

        

Accounts receivable

     (2,150     (9,118     (41,016     (14,381

Other current assets

     1,184       (1,125     (17,460     655  

Other non-current assets

     (2,017     (625     (10,054     (2,167

Accounts payable

     43,401       14,321       63,769       17,256  

Other current liabilities

     7,220       4,844       5,667       4,428  

Other long-term liabilities

     (206     (11     1,275       31  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by continuing operating activities

     90,858       33,857       115,149       66,327  

Net cash provided by (used in) discontinued operating activities

     —         15,609       (5,168     46,583  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by operating activities

     90,858       49,466       109,981       112,910  
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from investing activities

        

Purchase of property, plant and equipment

     (268     (124     (1,028     (955

Capitalized software development costs

     (2,557     (3,291     (8,159     (9,056

Purchase of intangible assets

     —         —         (1,950     —    

Consideration received from sale of fixed assets

     21       —         21       —    

Acquisitions, net of cash acquired

     —         —         (90,184     —    

Purchase of equity investment

     —         —         (20,000     —    

Investments in short-term deposits

     —         (37,590     —         (42,590

Maturities of short-term deposits

     —         5,000       17,590       13,100  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash used in continuing investing activities

     (2,804     (36,005     (103,710     (39,501

Net cash used in discontinued investing activities

     —         (1,214     —         (4,154
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash used in investing activities

     (2,804     (37,219     (103,710     (43,655
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from financing activities

        

Repayment of long-term loan

     —         (2,500     (85,000     (5,000

Proceeds from Recapitalization transaction, net

     (9,080     —         663,813       —    

Exercise of options

     1,545       243       1,887       904  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided (used in) continuing financing activities

     (7,535     (2,257     580,700       (4,096

Net cash provided (used in) discontinued financing activities

     —         —         —         —    
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided (used in) financing activities

     (7,535     (2,257     580,700       (4,096
  

 

 

   

 

 

   

 

 

   

 

 

 

Effect of exchange rate changes on cash and cash equivalents and restricted cash

     676       436       815       (12

Net change in cash and cash equivalents and restricted cash

     80,519       9,990       586,971       65,159  

Cash and cash equivalents and restricted cash at beginning of the period

     709,678       145,940       203,087       91,219  
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash and cash equivalents and restricted cash at end of the period

   $ 790,873     $ 156,366     $ 790,873     $ 156,366  
  

 

 

   

 

 

   

 

 

   

 

 

 
Iron Source (NYSE:IS)
過去 株価チャート
から 11 2024 まで 12 2024 Iron Sourceのチャートをもっと見るにはこちらをクリック
Iron Source (NYSE:IS)
過去 株価チャート
から 12 2023 まで 12 2024 Iron Sourceのチャートをもっと見るにはこちらをクリック